Overview

The Role of Nerve Blocks in Hip Arthroscopy

Status:
Withdrawn
Trial end date:
2020-02-07
Target enrollment:
0
Participant gender:
All
Summary
The goal of this study is to determine whether QL blocks reduce opioid consumption following arthroscopic hip surgery by decreasing postoperative pain. Considering the current opioid epidemic, the responsibility of physicians to help prevent addiction, and the increasing prevalence of arthroscopic hip surgeries, this study holds a tremendous potential benefit for future patients.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Columbia University
Treatments:
Ropivacaine
Criteria
Inclusion Criteria:

- Patients scheduled to receive unilateral arthroscopy hip surgery at Columbia
University Medical Center with Dr. Lynch.

Exclusion Criteria:

- Patients scheduled to receive bilaterally or staged hip arthroscopy.

- Patients unwilling to participate in the research.

- History of chronic opioid use.

- Contraindication or allergy to study medications, such as QL block.